This early-stage study tested an experimental mRNA vaccine called CVGBM in 37 people with a severe brain cancer (glioblastoma or a similar tumor). Participants received the vaccine after surgery and radiation. The main goal was to check safety and find the right dose. The vaccine…
Phase: PHASE1 • Sponsor: CureVac • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:08 UTC